Literature DB >> 15837193

Structure and inhibition of the human cell cycle checkpoint kinase, Wee1A kinase: an atypical tyrosine kinase with a key role in CDK1 regulation.

Christopher J Squire1, James M Dickson, Ivan Ivanovic, Edward N Baker.   

Abstract

Phosphorylation is critical to regulation of the eukaryotic cell cycle. Entry to mitosis is triggered by the cyclin-dependent kinase CDK1 (Cdc2), which is inactivated during the preceding S and G2 phases by phosphorylation of T14 and Y15. Two homologous kinases, Wee1, which phosphorylates Y15, and Myt1, which phosphorylates both T14 and Y15, mediate this inactivation. We have determined the crystal structure of the catalytic domain of human somatic Wee1 (Wee1A) complexed with an active-site inhibitor at 1.8 A resolution. Although Wee1A is functionally a tyrosine kinase, in sequence and structure it most closely resembles serine/threonine kinases such as Chk1 and cAMP kinases. The crystal structure shows that although the catalytic site closely resembles that of other protein kinases, the activation segment contains Wee1-specific features that maintain it in an active conformation and, together with a key substitution in its glycine-rich loop, help determine its substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837193     DOI: 10.1016/j.str.2004.12.017

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  36 in total

1.  Finite Element Analysis of the Mouse Distal Femur with Tumor Burden in Response to Knee Loading.

Authors:  Feifei Jiang; Shengzhi Liu; Andy Chen; Bai-Yan Li; Alexander G Robling; Jie Chen; Hiroki Yokota
Journal:  Int J Orthop (Hong Kong)       Date:  2018-02-28

2.  Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.

Authors:  Christopher J Matheson; Kimberly A Casalvieri; Donald S Backos; Philip Reigan
Journal:  ChemMedChem       Date:  2018-07-11       Impact factor: 3.466

3.  Activation domain-dependent degradation of somatic Wee1 kinase.

Authors:  Laura Owens; Scott Simanski; Christopher Squire; Anthony Smith; Jeff Cartzendafner; Valerie Cavett; Jennifer Caldwell Busby; Trey Sato; Nagi G Ayad
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

4.  A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export.

Authors:  Changqing Li; Mark Andrake; Roland Dunbrack; Greg H Enders
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

Review 5.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

6.  Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase.

Authors:  Yunsong Tong; Maricel Torrent; Alan S Florjancic; Kenneth D Bromberg; Fritz G Buchanan; Debra C Ferguson; Eric F Johnson; Loren M Lasko; David Maag; Philip J Merta; Amanda M Olson; Donald J Osterling; Nirupama Soni; Alexander R Shoemaker; Thomas D Penning
Journal:  ACS Med Chem Lett       Date:  2014-08-06       Impact factor: 4.345

7.  Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.

Authors:  Noriaki Tanaka; Ameeta A Patel; Jiping Wang; Mitchell J Frederick; Nene N Kalu; Mei Zhao; Alison L Fitzgerald; Tong-xin Xie; Natalie L Silver; Carlos Caulin; Ge Zhou; Heath D Skinner; Faye M Johnson; Jeffrey N Myers; Abdullah A Osman
Journal:  Clin Cancer Res       Date:  2015-06-29       Impact factor: 12.531

8.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis.

Authors:  A Vassilopoulos; Y Tominaga; H-Seok Kim; T Lahusen; B Li; H Yu; D Gius; C-X Deng
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

10.  Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase.

Authors:  Kengo Okamoto; Noriyuki Sagata
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.